Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Simcere Pharma of Nanjing in-licensed...
A Wall Street Journal article considered the future of...
Simcere Pharmaceutical Group...
Simcere Pharma signed a strategic...
Simcere Pharma has signed a second drug...
Simcere Pharma, a Nanjing company that...
Simcere, a Nanjing pharma, in-licensed...
Suzhou Alphamab Oncology and 3D Medicines (Beijing) will...
Nanjing's Simcere Pharma has acquired...
Simcere Pharma of Nanjing has filed with...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China